Lack of effect of the seretonin4 receptor agonist zacopride on ACTH secretion in normal men

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 49-51

  Lefebvre, H ^a,b   Contesse, V ^c   Delarue, C ^c   Kuhn, J M ^b   Vaudry, H ^c   Wolf, L M ^b  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE ROUEN   (France)

Author keywords

5 HT4 receptor; ACTH secretion; Benzamide derivatives; Cortisol secretion; Serotonin; Zacopride

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; HYDROCORTISONE; PLACEBO; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; ZACOPRIDE; BENZAMIDE DERIVATIVE; FUSED HETEROCYCLIC RINGS; SEROTONIN ANTAGONIST;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOUBLE BLIND PROCEDURE; GLOMERULOSA CELL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; ALDOSTERONE; ANALYSIS OF VARIANCE; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; HUMANS; HYDROCORTISONE; MALE; SEROTONIN ANTAGONISTS;

EID: 0029658234     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050159     Document Type: Article

References (17)

1. Fuller RW, Snoddy HD (1980) Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Neuroendocrinology 31: 96-100
2. Spinedi E, Negro-Vilar A (1983) Serotonin and adrenocorticotropin (ACTH) release: direct effects at the anterior pituitary level and potentiation of arginine vasopressin-induced ACTH release. Endocrinology 112: 1217-1223
3. Spinedi E, Gaillard RC (1991) Stimulation of the hypothalamopituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin. J Endocrinol Invest 14: 551-557
4. 2A/2C) receptors. J Pharmacol Exp Ther 271: 1647-1655
5. 3 antagonists. Psychoneuroendocrinology 20: 239-257
6. 3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures. Eur J Endocrinol 133: 251-254
7. 4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells. Mol Brain Res 10: 251-258
8. 4 receptor subtype. Neuroscience 47: 999-1007
9. 4 agonists and antagonists on steroid secretion by the adrenal gland in vitro. Eur J Pharmacol 265: 27-33
10. 4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-HT-induced steroid secretion. Mol Pharmacol 49: 481-493
11. Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn JM, Wolf LM, Vaudry H (1993) Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex. In vivo and in vitro studies. J Clin Endocrinol Metab 77: 1662-1666.
12. 4 receptor agonist cisapride and angiotensin II exert additive effects on aldosterone secretion in normal man. J Clin Endocrinol Metab 80: 504-507
13. 4) coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol 340: 403-410
14. Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ (1988) Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol 40: 302-305
15. Quinn SJ, Williams GH (1992) Regulation of aldosterone secretion. In: James VHT (ed) The adrenal gland. 2nd edn. Raven Press, New York, pp 159-189
16. Shenker Y, Gross MD, Grekin RJ (1985) Central serotonergic stimulation of aldosterone secretion. J Clin Invest 76: 1485-1490
17. 4 binding sites in rodent brain. Neuropharmacology 33: 527-541